Holen Sie sich die Stockscreener-App
8.96
3.58%
0.31
Handel nachbörslich:
8.98
0.02
+0.22%
Schlusskurs vom Vortag:
$8.65
Offen:
$9.09
24-Stunden-Volumen:
634.25K
Relative Volume:
2.33
Marktkapitalisierung:
$2.71B
Einnahmen:
$391.87M
Nettoeinkommen (Verlust:
$-441.45M
KGV:
-4.8432
EPS:
-1.85
Netto-Cashflow:
$-301.21M
1W Leistung:
+5.91%
1M Leistung:
+5.16%
6M Leistung:
-29.89%
1J Leistung:
-16.96%
1-Tages-Spanne:
$8.80
$9.09
1-Wochen-Bereich:
$8.31
$9.09
52-Wochen-Spanne:
$7.35
$13.70
Alvotech Stock (ALVO) Company Profile
Vergleichen Sie ALVO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ALVO
Alvotech
|
8.96 | 2.71B | 391.87M | -441.45M | -301.21M | -1.85 |
|
ZTS
Zoetis Inc
|
152.44 | 66.38B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.77 | 46.20B | 29.96B | 957.25M | 5.31B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.69 | 42.99B | 14.26B | 1.98B | 0 | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.21 | 19.04B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
309.72 | 13.63B | 2.99B | 1.21B | 1.13B | 25.06 |
Alvotech Stock (ALVO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-14 | Eingeleitet | UBS | Buy |
| 2024-01-29 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2023-10-20 | Hochstufung | Citigroup | Sell → Neutral |
| 2023-09-21 | Eingeleitet | Barclays | Equal Weight |
| 2022-09-07 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-09-06 | Herabstufung | Citigroup | Buy → Sell |
| 2022-07-26 | Eingeleitet | Citigroup | Buy |
Alle ansehen
Alvotech Aktie (ALVO) Neueste Nachrichten
Alvotech's Strategic Transformation and Financial Turnaround: A High-Conviction Buy Opportunity in Biosimilars - AInvest
Why Alvotech Shares Are Under Pressure - TipRanks
Alvotech earnings beat by $0.50, revenue topped estimates - Investing.com Nigeria
ALVOTECH Earnings Results: $ALVO Reports Quarterly Earnings - Quiver Quantitative
Alvotech Reports Strong H1 2025 Financials and Strategic Partnerships - TipRanks
Alvotech soars as product revenue surges over 200% YoY By Investing.com - Investing.com Australia
Alvotech soars as product revenue surges over 200% YoY - Investing.com
Alvotech : Q2 2025Unaudited Condensed Consolidated Interim Financial Statements first 6 months - MarketScreener
Alvotech Reports Results for the First Six Months of 2025 and Provides a Business Update - Yahoo Finance
Wall Street Analysts Think Alvotech (ALVO) Could Surge 102.31%: Read This Before Placing a Bet - Zacks Investment Research
Why Alvotech stock attracts strong analyst attentionMarket Trend Summary & Fast Moving Market Watchlists - thegnnews.com
Alvotech to Report Q2 2025 Earnings on August 13, 2025, with Webcast on August 14, 2025 - AInvest
Rogers Communications Raises Price Target to $33.00 Amidst Optimism for Future Performance - AInvest
Alvotech Rebounds From Oversold Zone — Now WhatAccurate Technical Trend Reversal Picks Detected - 선데이타임즈
Regression Model Predicts Rangebound Movement in AlvotechBuy Low Sell High Stock Watch Strategy in Focus - beatles.ru
Alvotech (ALVO) Projected to Post Earnings on Wednesday - MarketBeat
MACD Signals Flash Warning for Alvotech StockLow Risk High Return Opportunities Identified - beatles.ru
Alvotech WRT ALVOW 2025Q2 Earnings Preview Upside Ahead on Revenue Growth Forecast - AInvest
What are Alvotech’s recent SEC filings showingAdvanced Entry Signal Stocks - thegnnews.com
Screener Results Flag Alvotech as OversoldCapital Preserving Trade Plan Templates Shared - metal.it
What makes Alvotech stock price move sharplyTop 100 Low Volatility Gainers - thegnnews.com
Who’s Hired? Rosemont Gains A Chairperson But Loses A CEO - insights.citeline.com
Earnings Preview: Alvotech to Report Financial Results Post-market on August 13 - 富途牛牛
Alvotech shares rise 1.89% after-hours following FDA approval of Ajovy for pediatric migraine prevention. - AInvest
Alvotech Announces Webcast to Report Financial Results for the First Half of 2025 on August 14, 2025, at 8:00 Am EDT - 富途牛牛
Alvotech to Release First Half 2025 Financial Results and Host Conference Call - Quiver Quantitative
Alvotech Reports Q2 2025 Earnings: Webcast and Conference Call Set for August 14 - AInvest
Alvotech Announces Webcast to Report Financial Results for the First Half of 2025 on August 14, 2025, at 8:00 am EDT - Yahoo Finance
Alvotech Reaches Critical Trendline SupportTechnical Signal Trend Tracker Prediction - beatles.ru
Can Alvotech Rally Enough to Break EvenAI Driven Buy Alert Trade Blueprint Released - metal.it
What analysts say about Alvotech stockRemarkably fast returns - Jammu Links News
What drives Alvotech Equity Warrant stock priceCapitalize on fast-growing stocks today - Jammu Links News
What is Alvotech Equity Warrant company’s growth strategyGain insights from top financial experts - Jammu Links News
What are Alvotech company’s key revenue driversCapitalize on emerging investment opportunities - Jammu Links News
Is Alvotech a good long term investmentAccelerated capital growth - Jammu Links News
What markets is Alvotech expanding into Is BuzzFeed Inc. stock a good long term investment option - Jammu Links News
What is the dividend policy of Alvotech Equity Warrant stockInvest smarter and grow your wealth faster - Jammu Links News
How volatile is Alvotech Equity Warrant stock compared to the marketCapitalize on fast-moving trading opportunities - Jammu Links News
How does Alvotech generate profit in a changing economyMaximize your portfolio’s earning potential - Jammu Links News
What are analysts’ price targets for Alvotech in the next 12 monthsTremendous portfolio expansion - Jammu Links News
Does Alvotech Equity Warrant stock perform well during market downturnsInvest smarter with actionable trading signals - Jammu Links News
What is the risk reward ratio of investing in Alvotech stockRapidly expanding wealth - Jammu Links News
What are Alvotech Equity Warrant company’s key revenue driversGet exclusive market analysis for investors - Jammu Links News
How strong is Alvotech Equity Warrant company’s balance sheetBuild wealth steadily with proven stock picks - Jammu Links News
Does Alvotech stock perform well during market downturnsUnlock powerful stock screening for profits - Jammu Links News
What drives Alvotech stock priceTriple-digit growth rates - Jammu Links News
How volatile is Alvotech stock compared to the marketUnmatched profit growth - Jammu Links News
How strong is Alvotech company’s balance sheetOverwhelming financial success - Jammu Links News
Is it the right time to buy Alvotech Equity Warrant stockBuild wealth steadily with smart trading - Jammu Links News
What analysts say about Alvotech Equity Warrant stockFast-track wealth growth - Jammu Links News
What catalysts could drive Alvotech stock higher in 2025Unlock exclusive trading tools and resources - Jammu Links News
Finanzdaten der Alvotech-Aktie (ALVO)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.37%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):